A double agent in cancer: stopping macrophages wounds tumors.
Qualls
Joseph E
JE
Department of Infectious Diseases & Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Murray
Peter J
PJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D018821:CD18 Antigens / Q000276:immunology; D002464:Cell Migration Inhibition / Q000502:physiology*; D006801:Humans; D008264:Macrophages / Q000187:drug effects* / Q000276:immunology / Q000473:pathology / Q000528:radiation effects; D051379:Mice; D008819:Mice, Nude; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology / Q000473:pathology*; D011878:Radiotherapy / Q000009:adverse effects; D019139:Tumor Escape / Q000276:immunology / Q000528:radiation effects; D023041:Xenograft Model Antitumor Assays
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018821:CD18 Antigens